Orchestra BioMed Holdings (OBIO) Depreciation and Depletion (2022 - 2024)
Orchestra BioMed Holdings' (OBIO) quarterly Depreciation and Depletion came in at $84000.0 in Q4 2024, up 16.67% year-on-year from $72000.0 in Q1 2024, and up 10.53% on a QoQ basis from $76000.0 in Q3 2024.
Orchestra BioMed Holdings (OBIO) Depreciation and Depletion (2022 - 2024) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 3 years of Depreciation and Depletion data on file, last reported at $84000.0 in Q4 2024.
- On a quarterly basis, Depreciation and Depletion rose 16.67% year-over-year to $84000.0 in Q4 2024; TTM through Dec 2024 was $308000.0, a 7.69% increase from a year earlier, with the FY2025 full-year figure at $327000.0, up 6.17% from the prior year.
- Depreciation and Depletion for Q4 2024 stood at $84000.0, up from $76000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for OBIO reached as high as $84000.0 in Q4 2024 and fell as low as $48000.0 in Q1 2022.
- Historically, Depreciation and Depletion has averaged $67916.7 across 3 years, with a median of $71500.0 in 2023.
- Across the five-year window, Depreciation and Depletion soared 47.92% in 2023 and rose 2.78% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $70000.0 in 2022, then rose by 2.86% to $72000.0 in 2023, then advanced by 16.67% to $84000.0 in 2024.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $84000.0 in Q4 2024, $76000.0 in Q3 2024, and $74000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 84,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Mar 31, 2024 | 74,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Dec 31, 2023 | 72,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Sep 30, 2022 | 54,000.00 |